ACA Finalist - Offer Dilemma

Hi all,

To set the scene, I have been working in one of EY's UK regional offices (just outside London) within Audit for the past 3 years, so am about to sit final ACA exams in July. Before this I had worked for a year in an FP&A role at Sky, followed by a sales role recruiting in the Investment Banking industry.

My training contract is up in September and I started my search relatively early for new roles. I had originally sought out CF M&A roles both at EY and elsewhere, with some joy in terms of coffees etc. but nothing concrete.

However, I ended up with two offers, one of which I turned down as I didn't think it was right for me. The other offer, which is still an open offer, is at a Mid Market CF firm in London. This was through a cold approach (no live role), but is essentially for a Business Development role, focusing on PE Coverage and M&A Deal Origination.

I think this could be a great opportunity, particularly given a role has been created for me with a chance to make a real impact to deal-flow and revenue generation ultimately. I have really enjoyed sales roles in the past and have been fairly good at them.

My questions (mainly aimed at CF professionals with deal experience) are as follows:

Would working on Origination and PE Coverage mean that I could be limiting myself in the future in terms of never having perfomred the real "grunt work" directly on M&A deals?

(My role would entail initial analysis and there would be scope to remain a part of deals once they have been bought into the firm but this obviously won't be as involved as the associates working solely in core deal teams.)

How would an Origination/PE Coverage role compare to an "out and out" M&A role and has anyone done both, with a preference on either?

Based on this should I continue seeking out a more conventional M&A role or count myself lucky to have found a more unique role with clearer path to promotion (based on a small, new growing team)?

Any advice would be much appreciated!

Cheers, Josh

1 Comments
 

Expedita dolorem tempore sit quia dolorum ut dolorum. Non itaque aut suscipit quaerat quia dignissimos. Praesentium sint consectetur ipsam est aut voluptas. Cumque quia dolores perspiciatis non inventore officia dolore eum. Sapiente quia neque voluptates delectus.

Ratione ducimus qui quae architecto. Sunt nam autem odit. Doloremque repellat non in vel nam in. Corrupti aliquam tenetur earum ut sint.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”